31 – 40 of 149
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2022
-
Mark
Evaluation of revised classification criteria for giant cell arteritis and its clinical phenotypes
(
- Contribution to journal › Article
- 2021
-
Mark
Association Between Bone Mineral Density and Autoantibodies in Patients With Rheumatoid Arthritis
(
- Contribution to journal › Article
-
Mark
Predictors of unacceptable pain with and without low inflammation over 5 years in early rheumatoid arthritis-an inception cohort study
(
- Contribution to journal › Article
-
Mark
Autoantibodies in Rheumatoid Arthritis – Laboratory and Clinical Perspectives
(
- Contribution to journal › Scientific review
-
Mark
Comment on: EPIDEMIOLOGY OF BIOPSY-CONFIRMED GIANT CELL ARTERITIS IN SOUTHERN SWEDEN-AN UPDATE ON INCIDENCE AND FIRST PREVALENCE ESTIMATE: Reply
(
- Contribution to journal › Article
-
Mark
Epidemiology of biopsy-confirmed giant cell arteritis in southern Sweden - an update on incidence and first prevalence estimate
(
- Contribution to journal › Article
-
Mark
Trajectory of Healthcare Resources Utilization in Giant Cell Arteritis – A Population-Based Study
(
- Contribution to journal › Article
-
Mark
Predictors of radiographic erosion and joint space narrowing progression in patients with early rheumatoid arthritis: a cohort study
(
- Contribution to journal › Article
-
Mark
Proteomic data analysis for differential profiling of the autoimmune diseases SLE, RA, SS, and ANCA-associated vasculitis
(
- Contribution to journal › Article
-
Mark
Comment on : Negative associations for fasting blood glucose, cholesterol and triglyceride levels with the development of giant cell arteritis: Reply
(
- Contribution to journal › Letter